TW200640452A - Antifungal compositions - Google Patents

Antifungal compositions

Info

Publication number
TW200640452A
TW200640452A TW095106521A TW95106521A TW200640452A TW 200640452 A TW200640452 A TW 200640452A TW 095106521 A TW095106521 A TW 095106521A TW 95106521 A TW95106521 A TW 95106521A TW 200640452 A TW200640452 A TW 200640452A
Authority
TW
Taiwan
Prior art keywords
hydrocortisone
mixtures
pharmaceutically acceptable
effective amount
antifungal compositions
Prior art date
Application number
TW095106521A
Other languages
English (en)
Inventor
Celia Palacin
Marta Guerrero
Jesus Torres
Manuel M Raga
Antonio Guglietta
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of TW200640452A publication Critical patent/TW200640452A/zh

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J1/00—Details of electrodes, of magnetic control means, of screens, or of the mounting or spacing thereof, common to two or more basic types of discharge tubes or lamps
    • H01J1/02—Main electrodes
    • H01J1/30—Cold cathodes, e.g. field-emissive cathode

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Manufacturing & Machinery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
TW095106521A 2005-03-01 2006-02-27 Antifungal compositions TW200640452A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05101540A EP1698336A1 (en) 2005-03-01 2005-03-01 Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent

Publications (1)

Publication Number Publication Date
TW200640452A true TW200640452A (en) 2006-12-01

Family

ID=34938848

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095106521A TW200640452A (en) 2005-03-01 2006-02-27 Antifungal compositions

Country Status (16)

Country Link
US (1) US20080166398A1 (zh)
EP (2) EP1698336A1 (zh)
JP (1) JP2008531640A (zh)
KR (1) KR20070107806A (zh)
CN (1) CN101137362A (zh)
AR (1) AR053688A1 (zh)
AU (1) AU2006219903A1 (zh)
BR (1) BRPI0607561A2 (zh)
CA (1) CA2598598A1 (zh)
MX (1) MX2007010703A (zh)
NO (1) NO20074945L (zh)
PE (1) PE20061241A1 (zh)
RU (1) RU2007136169A (zh)
TW (1) TW200640452A (zh)
UY (1) UY29402A1 (zh)
WO (1) WO2006092374A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8057433B2 (en) 2004-07-08 2011-11-15 Drugtech Corporation Delivery system
EP2271328A4 (en) * 2008-03-20 2011-09-07 Alda Pharmaceuticals Corp ANTISEPTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS
EP2177208A1 (en) * 2008-10-17 2010-04-21 Ferrer Internacional, S.A. Pharmaceutical topical compositions
CN103156862B (zh) * 2013-03-28 2015-04-29 孙国栋 一种复方伏立康唑滴耳剂及其制备方法
US20180021329A1 (en) * 2015-02-13 2018-01-25 Maruho Co., Ltd. External preparation comprising pyridonecarboxylic acid derivative
BR112018077430A2 (pt) * 2016-07-08 2019-04-02 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A composição farmacêutica.
CN113520993B (zh) * 2021-07-30 2022-07-29 海南海神同洲制药有限公司 一种低粘度硝酸舍他康唑乳膏的制备方法及其制备的产品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407663A (en) * 1991-04-11 1995-04-18 Eisen; Drore Method of treating inflammatory conditions of the mouth using steroid containing mouthwash which may contain antifungal agents
US5578315A (en) * 1993-12-01 1996-11-26 Rutgers, The State University Of New Jersey Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
DK1070713T3 (da) * 1998-04-06 2006-12-27 Toyama Chemical Co Ltd Quinoloncarboxylsyrederivater eller salte deraf
KR100640039B1 (ko) * 2001-09-04 2006-10-31 트롬스도르프 게엠베하 운트 코. 카게 알츠나이미텔 세르타코나졸을 포함하며, 손발톱의 기능장애와 질환을치료하기 위한 플라스터
US20030091540A1 (en) * 2001-10-16 2003-05-15 Nawaz Ahmad Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity
ES2203316B1 (es) * 2002-02-11 2005-03-01 Ferrer Internacional, S.A. R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.
US20040176337A1 (en) * 2002-12-31 2004-09-09 Wockhardt Limited Benzoquinolizine-2-carboxylic acid-containing compositions
JP4540667B2 (ja) * 2003-03-21 2010-09-08 ネクスメツド・ホールデイングス・インコーポレイテツド 抗真菌性ネイルコート

Also Published As

Publication number Publication date
WO2006092374A1 (en) 2006-09-08
RU2007136169A (ru) 2009-04-10
BRPI0607561A2 (pt) 2009-09-15
MX2007010703A (es) 2007-10-12
PE20061241A1 (es) 2006-11-13
UY29402A1 (es) 2006-06-30
NO20074945L (no) 2007-11-21
CA2598598A1 (en) 2006-09-08
JP2008531640A (ja) 2008-08-14
US20080166398A1 (en) 2008-07-10
AR053688A1 (es) 2007-05-16
AU2006219903A1 (en) 2006-09-08
KR20070107806A (ko) 2007-11-07
CN101137362A (zh) 2008-03-05
EP1858510A1 (en) 2007-11-28
EP1698336A1 (en) 2006-09-06

Similar Documents

Publication Publication Date Title
TW200640452A (en) Antifungal compositions
WO2004062601A3 (en) Antibacterial agents
ECSP077239A (es) Formulación farmacéutica
WO2018208985A3 (en) Antibacterial compounds
EP2662353A3 (en) Antibacterial agents
WO2012032360A3 (en) Novel use
WO2003091276A3 (en) Compositions and methods of use of peptides in combination with biocides and/or germicides
EP2279662A3 (en) 5,7,4'-trihydroxy-3',5'-dimethoxyflavone as an antibacterial agent
WO2007138110A3 (en) Compounds that interact with ion channels, in particular with ion channels from the kv family
WO2011047439A8 (en) Novel parasite therapy
WO2006081431A3 (en) Compounds for treating inflammatory and demyelinating diseases
WO2010115184A3 (en) Hydroxythienoquinolones and related compounds as anti-infective agents
WO2007134777A3 (de) Fungizide wirkstoffkombinationen
EP2889034A3 (en) Compositions and methods of treatment comprising ceftaroline
WO2007064620A3 (en) Compositions comprising a combination of ccr5 and cxcr4 antagonists
EP3760626A4 (en) NEW COMPOUND AND COMPOSITION FOR THE PREVENTION, IMPROVEMENT OR TREATMENT OF FIBROSIS OR NON-ALCOHOLIC STEATOHEPATITIS, INCLUDING IT AS AN ACTIVE SUBSTANCE
WO2004093792A3 (en) Compositions and methods for treating body malodor and fungal overgrowth in mammals
MY136090A (en) Fungicidal composition based on a pyridylmethylbenzamide derivative and a valinamide drivative
PH12019502652A1 (en) 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases
WO2011042473A3 (en) Estrogen receptor ligands
AR064152A1 (es) Derivados de quinolina antibacterianos,composiciones farmaceuticas que los contienen y metodo de preparacion.
MY137868A (en) Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation and ummunologically-mediated diseases
WO2010030811A3 (en) CARBACEPHEM β-LACTAM ANTIBIOTICS
WO2009038411A3 (en) Beta-secretase inhibiting compounds having oxo-dihydro-pyrazole moiety
WO2007047881A3 (en) Method for treating neuropathic pain